In-hospital and long-term outcome of patients with mitral valve replacement with and without retethering technique
- Conditions
- mitral valve replacement
- Registration Number
- DRKS00032902
- Lead Sponsor
- niversitätsklinikum Magdeburg A.ö.R. Klinik für Herz- und Thoraxchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
•Patients who have had mitral valve replacement surgery since 2017
Exclusion Criteria
•Lack of patient consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint will be periprocedural mortality as defined by VARC-3 criteria. <br>
- Secondary Outcome Measures
Name Time Method Secondary endpoints will be: <br>1.Patient mortality (up to 3 years)<br>2.Frequency of an LVR<br>3.Echocardiographic data on ventricle and valve function before surgery and in the short and long term as well as integrity of the patch (intrahospital , 30 days, 6 months, 1 year, max. 3 years if applicable)<br>4.Frequency of secondary bleeding and reoperation during hospital stay<br>5.Rate of pacemaker requirement during hospital stay<br>6.Length of hospital stay<br>8.Course parameters of the hospital stay: laboratory values, transfusions<br>